11. Immunogenicity and safety of the BNT162b2 mRNA COVID‐19 vaccine in haematopoietic stem cell transplantation recipients. (28th October 2021) Authors: Shem‐Tov, Noga; Yerushalmi, Ronit; Danylesko, Ivetta; Litachevsky, Vladislav; Levy, Itzchak; Olmer, Liraz; Lusitg, Yaniv; Avigdor, Abraham; Nagler, Arnon; Shimoni, Avichai; Rahav, Galia Journal: British journal of haematology Issue: Volume 196:Number 4(2022) Page Start: 884 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
12. Long-term survival and late events after allogeneic stem cell transplantation from HLA-matched siblings for acute myeloid leukemia with myeloablative compared to reduced-intensity conditioning: a report on behalf of the acute leukemia working party of European group for blood and marrow transplantation. Issue 1 (December 2016) Authors: Shimoni, Avichai; Labopin, Myriam; Savani, Bipin; Volin, Liisa; Ehninger, Gerhard; Kuball, Jurgen; Bunjes, Donald; Schaap, Nicolaas; Vigouroux, Stephane; Bacigalupo, Andrea; Veelken, Hendrik; Sierra, Jorge; Eder, Matthias; Niederwieser, Dietger; Mohty, Mohamad; Nagler, Arnon Journal: Journal of hematology & oncology Issue: Volume 9:Issue 1(2016) Page Start: 1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
13. Long‐term outcome after a treosulfan‐based conditioning regimen for patients with acute myeloid leukemia: A report from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation. Issue 14 (22nd March 2017) Authors: Nagler, Arnon; Labopin, Myriam; Beelen, Dietrich; Ciceri, Fabio; Volin, Liisa; Shimoni, Avichai; Foá, Roberto; Milpied, Noel; Peccatori, Jacopo; Polge, Emmanuelle; Mailhol, Audrey; Mohty, Mohamad; Savani, Bipin N. Journal: Cancer Issue: Volume 123:Issue 14(2017) Page Start: 2671 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
14. Missing HLA C group 1 ligand in patients with AML and MDS is associated with reduced risk of relapse and better survival after allogeneic stem cell transplantation with fludarabine and treosulfan reduced toxicity conditioning. Issue 10 (19th July 2017) Authors: Shimoni, Avichai; Vago, Luca; Bernardi, Massimo; Yerushalmi, Ronit; Peccatori, Jacopo; Greco, Raffaella; Shem‐Tov, Noga; Lo Russo, Alessandro; Danylesko, Ivetta; Apel, Arie; Bonini, Chiara; Lupo Stanghellini, Maria Teresa; Nagler, Arnon; Ciceri, Fabio Journal: American journal of hematology Issue: Volume 92:Issue 10(2017:Oct.) Page Start: 1011 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
15. Modification of heparanase gene expression in response to conditioning and LPS treatment: strong correlation to rs4693608 SNP. Issue 4 (6th December 2013) Authors: Ostrovsky, Olga; Shimoni, Avichai; Baryakh, Polina; Morgulis, Yan; Mayorov, Margarita; Beider, Katia; Shteingauz, Anna; Ilan, Neta; Vlodavsky, Israel; Nagler, Arnon Journal: Journal of leukocyte biology Issue: Volume 95:Issue 4(2014) Page Start: 677 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
16. Monoclonal antibody-based immunotherapy for multiple myeloma. (September 2012) Authors: Danylesko, Ivetta; Beider, Katia; Shimoni, Avichai; Nagler, Arnon Journal: Immunotherapy Issue: Volume 4:Number 9(2012:Sep.) Page Start: 919 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
17. Novel Strategies for Immunotherapy in Multiple Myeloma: Previous Experience and Future Directions. (10th May 2012) Authors: Danylesko, Ivetta; Beider, Katia; Shimoni, Avichai; Nagler, Arnon Other Names: Kröger Nicolaus Academic Editor. Journal: Clinical & developmental immunology Issue: Volume 2012(2012) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
18. OCT1 genetic variants are associated with long term outcomes in imatinib treated chronic myeloid leukemia patients. (18th December 2013) Authors: Koren‐Michowitz, Maya; Buzaglo, Zehavit; Ribakovsky, Elena; Schwarz, Michaela; Pessach, Ilias; Shimoni, Avichai; Beider, Katia; Amariglio, Ninette; Ie Coutre, Philipp; Nagler, Arnon Journal: European journal of haematology Issue: Volume 92:Number 4(2014:Apr.) Page Start: 283 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
19. Phase 1/2 study of nilotinib prophylaxis after allogeneic stem cell transplantation in patients with advanced chronic myeloid leukemia or Philadelphia chromosome–positive acute lymphoblastic leukemia. Issue 6 (11th November 2014) Authors: Shimoni, Avichai; Volchek, Yulia; Koren‐Michowitz, Maya; Varda‐Bloom, Nira; Somech, Raz; Shem‐Tov, Noga; Yerushalmi, Ronit; Nagler, Arnon Journal: Cancer Issue: Volume 121:Issue 6(2015) Page Start: 863 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
20. Point-of-care CAR T-cell therapy as salvage strategy for out-of-specification tisagenlecleucel. Issue 14 (6th December 2022) Authors: Fried, Shalev; Shouval, Roni; Varda-Bloom, Nira; Besser, Michal J.; Yerushalmi, Ronit; Shem-Tov, Noga; Danylesko, Ivetta; Jacoby, Elad; Teihman, Shlomit; Itzhaki, Orit; Fein, Joshua A.; Kedmi, Meirav; Shimoni, Avichai; Nagler, Arnon; Avigdor, Abraham Journal: Leukemia & lymphoma Issue: Volume 63:Issue 14(2022) Page Start: 3385 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗